|8.40||+0.15 / +1.82%|
As of 4:00pm ET
|8.40||0.00 / 0.00%|
The 1 analysts offering 12-month price forecasts for Northwest Biotherapeutics Inc have a median target of 15.10, with a high estimate of 15.10 and a low estimate of 15.10. The median estimate represents a +79.76% increase from the last price of 8.40.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.